(Q41530973)

2 October 2017

Circulating miR-375 and miR-199a-3p as potential biomarkers for the diagnosis of hepatocellular carcinoma (English)

1 reference

2 October 2017

1 reference

Jian Yin

1

1 reference

2 October 2017

Peng Hou

2

1 reference

2 October 2017

Zhiqiang Wu

3

1 reference

2 October 2017

Tao Wang

4

1 reference

2 October 2017

Yanxiao Nie

5

1 reference

2 October 2017

25 January 2015

1 reference

2 October 2017

1 reference

2 October 2017

36

1 reference

2 October 2017

6

1 reference

2 October 2017

4501-4507

1 reference

https://scigraph.springernature.com/pub.10.1007/s13277-015-3092-0

2 October 2017

0 references

cites work

Primary liver cancer: worldwide incidence and trends

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-3092-0

Biomarkers: evaluation of screening for and early diagnosis of hepatocellular carcinoma in Japan and china

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-3092-0

Prevention of hepatocellular carcinoma in the Asia-Pacific region: consensus statements

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-3092-0

Hepatocellular carcinoma in the Asia pacific region

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-3092-0

Evaluation of individual and combined applications of serum biomarkers for diagnosis of hepatocellular carcinoma: a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-3092-0

Risk factors for hepatocellular carcinoma in hepatitis C patients with normal alanine aminotransferase treated with pegylated interferon and ribavirin

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-3092-0

Expression and prognostic significance of golgiglycoprotein73 (GP73) with epithelial-mesenchymal transition (EMT) related molecules in hepatocellular carcinoma (HCC).

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-3092-0

Biomarkers for hepatocellular carcinoma: progression in early diagnosis, prognosis, and personalized therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-3092-0

Management of hepatocellular carcinoma: An update

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-3092-0

Expression of GOLM1 correlates with prognosis in human hepatocellular carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-3092-0

MicroRNA microarray expression profiling in human myocardial infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-3092-0

Protein lysate microarray analysis to identify microRNAs regulating estrogen receptor signaling in breast cancer cell lines

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-3092-0

Emerging personalized oncology: sequencing and systems strategies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-3092-0

Advances in understanding cancer genomes through second-generation sequencing

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-3092-0

Genome-wide association studies and genetic risk assessment of liver diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-3092-0

Capn4 overexpression underlies tumor invasion and metastasis after liver transplantation for hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-3092-0

Lectin-based glycoproteomics to explore and analyze hepatocellular carcinoma-related glycoprotein markers

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-3092-0

MicroRNA gene expression profile of hepatitis C virus-associated hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-3092-0

The clinical potential of microRNAs

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-3092-0

Prognostic value of miR-96 in patients with acute myeloid leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-3092-0

Identification of aberrant microRNA expression pattern in pediatric gliomas by microarray

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-3092-0

Reduced expression of miR-22 in gastric cancer is related to clinicopathologic characteristics or patient prognosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-3092-0

Profiles of serum microRNAs; miR-125b-5p and miR223-3p serve as novel biomarkers for HBV-positive hepatocellular carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-3092-0

Circulating microRNAs (cmiRNAs) as novel potential biomarkers for hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-3092-0

Circulating miR-15b and miR-130b in serum as potential markers for detecting hepatocellular carcinoma: a retrospective cohort study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-3092-0

MicroRNA expression patterns to differentiate pancreatic adenocarcinoma from normal pancreas and chronic pancreatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-3092-0

miR-199a-3p displays tumor suppressor functions in papillary thyroid carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-3092-0

Aberrant expression of miR-199a-3p and its clinical significance in colorectal cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-3092-0

The etiology of hepatocellular carcinoma and consequences for treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-3092-0

MicroRNAs: small RNAs with a big role in gene regulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-3092-0

Five microRNAs in plasma as novel biomarkers for screening of early-stage non-small cell lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-3092-0

A pancreatic islet-specific microRNA regulates insulin secretion

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-3092-0

MicroRNA-375 targets AEG-1 in hepatocellular carcinoma and suppresses liver cancer cell growth in vitro and in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-3092-0

MiR-375 frequently downregulated in gastric cancer inhibits cell proliferation by targeting JAK2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-3092-0

MicroRNA expression in squamous cell carcinoma and adenocarcinoma of the esophagus: associations with survival

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-3092-0

Epigenetically deregulated microRNA-375 is involved in a positive feedback loop with estrogen receptor alpha in breast cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-3092-0

Decreased circulating miR-375: a potential biomarker for patients with non-small-cell lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-3092-0

Prognostic significance of microRNA-375 downregulation in solid tumors: a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-3092-0

Clinical significance of serum miR-223, miR-25 and miR-375 in patients with esophageal squamous cell carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-3092-0

Correlation of microRNA-375 downregulation with unfavorable clinical outcome of patients with glioma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-3092-0

Cell-specific detection of miR-375 downregulation for predicting the prognosis of esophageal squamous cell carcinoma by miRNA in situ hybridization

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-3092-0

MicroRNA-375 inhibits tumour growth and metastasis in oesophageal squamous cell carcinoma through repressing insulin-like growth factor 1 receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-3092-0

Association of MicroRNA expression in hepatocellular carcinomas with hepatitis infection, cirrhosis, and patient survival.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-3092-0

Identification of novel microRNA targets based on microRNA signatures in bladder cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-3092-0

MiR-199a-3p regulates mTOR and c-Met to influence the doxorubicin sensitivity of human hepatocarcinoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-3092-0

Ultrasonographic surveillance of hepatocellular carcinoma in cirrhosis: A randomized trial comparing 3- and 6-month periodicities

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-3092-0

MicroRNA-375 targets PDK1 in pancreatic carcinoma and suppresses cell growth through the Akt signaling pathway

21 January 2018

1 reference

12 December 2020

Low expression of BARX2 in human primary hepatocellular carcinoma correlates with metastasis and predicts poor prognosis

1 reference

12 December 2020

Circulating microRNA-122a as a diagnostic marker for hepatocellular carcinoma

1 reference

12 December 2020

Hepatocellular carcinoma

1 reference

12 December 2020

Expression and significance of the novel tumor-suppressor gene SMG-1 in hepatocellular carcinoma

1 reference

12 December 2020

Alpha-foetoprotein and/or liver ultrasonography for screening of hepatocellular carcinoma in patients with chronic hepatitis B

1 reference

12 December 2020

miR-21 and miR-375 microRNAs as candidate diagnostic biomarkers in squamous cell carcinoma of the larynx: association with patient survival.

1 reference

12 December 2020

Genome-wide association study identifies a susceptibility locus for HCV-induced hepatocellular carcinoma

1 reference

12 December 2020

10.1007/S13277-015-3092-0

Identifiers

DOI

1 reference

Dimensions Publication ID

2 October 2017

0 references

1 reference